Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06980298

Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders

Toxoplasma gondii is recognized as being involved in the etiology of various psychotic disorders including epilepsy and ADHD (Markovitz et al.,2015).

There are many explanations for such associations between toxoplasmosis and neurological disorders which include many anatomical and neurotransmitter-related changes. Toxoplasmosis may cause alterations in neurotransmitter levels like serotonin, noradrenaline, glutamate, nitric oxide and gamma aminobutyric acid, increase in the levels of proinflammatory cytokines and modulate the dopaminergic signaling (Babaie et al., 2017). The behavioral changes produced by the cyst formation in the brain tissue may also related to the localization of the cyst within specific parts of the brain and this is assumed to be one of the main causes of epilepsy in toxoplasmosis. Moreover, tachyzoites may invade the brain tissues and excite brain cells especially neurons, microglia and astrocytes. Additionally, the presence of Toxoplasma in brain evokes inflammatory response and stimulate immune system to produce antibodies with increase in proinflammatory cytokines. Interestingly, some studies described that many host genes and proteins could be affected by Toxoplasma, signifying its involvement in many genetic disorders including neuropsychiatric diseases.The current study aimed to assess the seroprevalence of anti-Toxoplasma IgM and IgG antibodies among children with some neuropsychiatric disorders (Epilepsy and ADHD) in Sohag governorate, Egypt.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

Up to 15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag University

Sohag, Egypt

Location contact

Alaa Abd Elhamid Elsayed, Demonstrator

CONTACT

[email protected]

+201100546404

Alaa Abd Elhamid Elsayed, Demonstrator

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children with neuropsychiatric disorders (epilepsy,ADHD). Exclusion criteria: Children with history of neurosurgery, head injury or trauma, neoplastic or autoimmune diseases, or receiving immunosuppressant or systemic corticosteroid, and those with possible neurological infection.

Treatment and study plan

Primary outcomes

  1. Comparison between incidence of Toxoplasma gondii in children with neuropsychiatric disorders and children without neuropsychiatric disorders

    Time frame: 6 months

Secondary outcomes

  1. Prevalence of Toxoplasma gondii in children with neuropsychiatric disorders

    Time frame: 4 months

Study contacts

Contact information is provided by the study sponsor or research team.

Alaa Abd Elhamid Elsayed, Demonstrator

CONTACT

[email protected]

+201100546404

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders in Sohag Governorate, Egypt

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
May 20, 2025
Registry last updated
May 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.